Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.34 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.34 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1766510 | 0.94 | RXFP1 (0.35) | RXFP1MEN1MAPTKMT2AGPBAR1 | |
| SCHEMBL29427441 | 0.94 | RXFP1 (0.35) | RXFP1MEN1MAPTKMT2AGPBAR1 | |
| SCHEMBL20846798 | 0.94 | RXFP1 (0.37) | RXFP1MEN1NPC1MAPTRAB9A | |
| SCHEMBL29427437 | 0.93 | KCNK3 (0.38) | RXFP1KCNK3KCNK9GPBAR1CTSS | |
| SCHEMBL1766623 | 0.93 | KCNK3 (0.38) | RXFP1KCNK3KCNK9GPBAR1CTSS | |
| SCHEMBL20846841 | 0.92 | RORC (0.35) | RXFP1KCNK3KCNK9GPBAR1CTSS | |
| SCHEMBL20846803 | 0.92 | RXFP1 (0.38) | RXFP1RAB9AGPBAR1PTGES | |
| SCHEMBL25805064 | 0.92 | PTGES (0.32) | RXFP1KCNK3KCNK9GPBAR1CTSS | |
| SCHEMBL20846769 | 0.91 | NR1H4 (0.33) | RXFP1KMT2AGPBAR1CTSSPTGES | |
| SCHEMBL20846845 | 0.91 | HDAC8 (0.35) | RXFP1CTSSPTGESHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226037-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20230226037-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2023-07-20 | — | — | US | disclosed |
| US-11696913-B2 | Prolonged ectoparasite-controlling agent for animal | MITSUI CHEMICALS AGRO, INC. (JP) | 2023-07-11 | — | — | US | disclosed |
| US-11696913-B2 | Prolonged ectoparasite-controlling agent for animal | MITSUI CHEMICALS AGRO, INC. (JP) | 2023-07-11 | — | — | US | disclosed |
| US-20200281914-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MITSUI CHEMICALS AGRO, INC. (JP) | 2020-09-10 | — | — | US | disclosed |
| WO-2019059412-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MITSUI CHEMICALS AGRO, INC. (JP) | 2019-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11696913-B2 | Prolonged ectoparasite-controlling agent for animal | MTX1, ENPP1, CAT | RXFP1 1867/4885MEN1 686/4885NPC1 2692/4885 |
| US-20230226037-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MTX1, ENPP1, CAT | RXFP1 1867/4885MEN1 686/4885NPC1 2692/4885 |
| US-20200281914-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MTX1, ENPP1, CAT | RXFP1 1867/4885MEN1 686/4885NPC1 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.